The impact of comorbidities on the in-hospital mortality in patients with community-acquired pneumonia D Miteva, Y Radkov, V Kostadinova, A Dyakova European Respiratory Journal 46 (suppl 59), 2015 | 5 | 2015 |
Comparison of the prognostic value of different severity scales in community-acquired pneumonia D Miteva, V Kostadinova, Y Radkov, I Mircheva European Respiratory Journal 44 (Suppl 58), 2014 | 3 | 2014 |
In-hospital mortality risk assessment in patients with community acquired pneumonia V Kostadinova, D Miteva, Y Radkov, I Mircheva European Respiratory Journal 44 (Suppl 58), 2014 | 3 | 2014 |
Sputum microbiology in patients with stabile COPD V Kostadinova, Y Radkov, T Stoeva, D Miteva, A Dyakova European Respiratory Journal 46 (suppl 59), 2015 | 2 | 2015 |
Prognostic value of pro-adrenomedullin, procalcitonin and C-reactive protein in community acquired pneumonia D Miteva, Y Radkov, L Ivanova, T Chervenkov, V Kostadinova CBU International Conference Proceedings 5, 978-982, 2017 | 1 | 2017 |
Impact of bronchiectasis on the course of COPD V Kostadinova, Y Radkov, T Stoeva, D Miteva European Respiratory Journal 48 (suppl 60), 2016 | 1 | 2016 |
Role of procalcitonin in predicting severity and in-hospital mortality in patients with community-acquired pneumonia D Miteva, Y Radkov, L Ivanova, T Chervenkov, V Kostadinova European Respiratory Journal 48 (suppl 60), 2016 | 1 | 2016 |
IMMUNOMODULATORS IN PULMOLOGIGAL PRACTICE D Petkova, Z Odzhakova, Y Radkov, T Mavrodinova, A Karaivanova Scripta Scientifica Medica 28, 199-200, 1991 | 1 | 1991 |
Long-term azithromycin treatment in chronic obstructive pulmonary disease V Kostadinova, Y Radkov, T Stoeva, D Miteva Journal of IMAB–Annual Proceeding Scientific Papers 26 (3), 3259-3266, 2020 | | 2020 |
Relationship of HRCT-diagnosed emphysema and clinical features in COPD. V Kostadinova, Y Radkov, T Stoeva, D Miteva European Respiratory Journal 52 (suppl 62), 2018 | | 2018 |
ROLE OF C-REACTIVE PROTEIN IN SEVERITY ASSESSMENT AND MONITORING OF HOSPITALIZED PATIENTS WITH COMMUNITY-ACQUIRED PNEUMONIA D Miteva, Y Radkov, V Kostadinova International Scientific and Practical Conference World science 5 (6), 23-28, 2018 | | 2018 |
Role of some biomarkers in determining the risk of mortality of hospitalized patients with community-acquired pneumonia D Miteva, Y Radkov, L Ivanova, V Kostadinova, T Chervenkov Scripta Scientifica Medica 49 (4), 58-63, 2017 | | 2017 |
Six months azithromycin treatment in COPD patients with high risk of further exacerbations V Kostadinova, Y Radkov, T Stoeva, D Miteva European Respiratory Journal 50 (suppl 61), 2017 | | 2017 |
Характеристика на пневмонията придобита в обществото при пациенти с придружаваща хронична обструктивна белодробна болест ЙР Ваня Костадинова, Дарина Митева Medpost, 32-37, 2016 | | 2016 |
Белодробни и извънбелодробни усложнения при хоспитализирани пациенти с пневмония придобита в обществото VD D Miteva, Y Radkov, V Kostadinova Списание MD, 78-82, 2016 | | 2016 |
Белодробна пневмония или туберкулоза - диагностични проблеми ЙР Ваня Костадинова, Дарина Митева Medpost, 42, 2016 | | 2016 |
Последни новини около проблема кашлица ВК Йордан Радков Списание "InSpiro", 29-32, 2016 | | 2016 |
COPD EXACERBATIONS AND C-REACTIVE PROTEIN V Kostadinova, Y Radkov, T Stoeva, D Miteva Официален орган на Българското Дружество по Белодробни Болести, 35, 2015 | | 2015 |
Clinical characteristics and prognosis of community-acquired pneumonia in patients with concomitant diabetes mellitus YR D Miteva Thoracic Medicine 7 (2), 54-62, 2015 | | 2015 |
Нови аспекти в стратификацията на риска при пациенти с пневмония, придобита в обществото YR D Miteva, V Kostadinova Наука Пулмология, 31-39, 2015 | | 2015 |